2017
Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice
Rosenberg SA, Baschnagel AM, Bagley SJ, Housri N. Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice. Current Oncology Reports 2017, 19: 5. PMID: 28168606, DOI: 10.1007/s11912-017-0563-z.Peer-Reviewed Original ResearchConceptsStereotactic body radiotherapyNon-small cell lung cancer (NSCLC) treatmentCell lung cancer treatmentLung cancer treatmentNational clinical trialEvidence-based treatmentsEvidence-based medicineTranslating EvidenceCommunity oncologistsBody radiotherapyLung cancerClinical trialsPreclinical discoveryClinical practiceCommunity settingsCancer treatmentOncologistsCommunity practiceTreatmentMedicineImmunotherapyNSCLCInternet-based resourcesRadiotherapyCancer
2014
Adult Cancer Clinical Trials That Fail to Complete: An Epidemic?
Stensland K, McBride R, Latif A, Wisnivesky J, Hendricks R, Roper N, Boffetta P, Hall S, Oh W, Galsky M. Adult Cancer Clinical Trials That Fail to Complete: An Epidemic? Journal Of The National Cancer Institute 2014, 106: dju229. PMID: 25190726, DOI: 10.1093/jnci/dju229.Peer-Reviewed Original ResearchConceptsClinical trialsCancer clinical trialsNational Cancer InstituteCumulative incidence of failureCooperative group trialsStandard therapeutic approachClinical drug developmentIncidence of failureCumulative incidenceEligible patientsPreclinical discoveryTherapeutic approachesCancer therapeuticsCancer InstituteCancer biologyCancerPatientsNew therapeuticsTherapeutic targetGroup trialClinical trial enterpriseTrialsDrug to marketDrug developmentClinical trial systemEnzalutamide: looking back at its preclinical discovery
Ha Y, Kim I. Enzalutamide: looking back at its preclinical discovery. Expert Opinion On Drug Discovery 2014, 9: 837-845. PMID: 24820058, DOI: 10.1517/17460441.2014.918947.Peer-Reviewed Original ResearchConceptsCastration-recurrent PCaFirst-line therapyProstate cancerClinical developmentCastration-recurrent prostate cancerStandard first-line therapyAndrogen-AR axisAR agonist activityMetastatic prostate cancerAR nuclear translocationSelective AR modulatorsFurther clinical studiesAndrogen receptor antagonistPre-clinical discoveryDrug clinical developmentSequential therapyOverall survivalTargeted agentsReceptor antagonistClinical studiesPreclinical discoveryNew agentsAR modulatorsAgonist activityFDA approval
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply